Opioid Tapering: Unpacking the Risks and Realities
I think everyone talks about how, like they, you know, every time they update the guidelines, everyone changes their practice very drastically, I think, for most people that have read them.
What happens when patients on long-term opioid therapy face tapering or abrupt discontinuation? Dr. Sonya Del Tredici and Dr. John Keenan dive into this pressing issue in episode 8 of 'Addiction Medicine Journal Club'. They unpack a recent study published in JAMA Network Open, shedding light on the comparative risks of opioid tapering versus no dosage change, particularly focusing on overdose and suicide rates.
The discussion isn't just about numbers; it touches on the human side of opioid use and the complexities doctors and patients navigate daily. They also delve into the history of opioid prescribing guidelines, revealing how these rules have evolved and impacted both healthcare providers and those they treat. Adding another layer to the conversation, the hosts examine the limitations of database studies and why individualized treatment plans are crucial in addiction medicine.
They don’t shy away from controversial topics either, bringing up the recent Ruan vs. United States Supreme Court decision about pill mills. By the end of the episode, listeners are left pondering a significant question: How should the medical community address its role in the ongoing opioid epidemic? This episode is a must-listen for anyone interested in understanding the delicate balance between managing chronic pain and preventing addiction.